Richard S.E. Keefe

Professor in Psychiatry and Behavioral Sciences

Education & Training

  • Ph.D., New York University 1990

Overview

Schizophrenia, psychosis, cognition, pharmacologic treatment of cognitive impairment, sport psychology, functional imaging (PET, fMRI), frontal cortex, motor functions.

Lam, M, Wang, M, Huang, W, Eng, GK, Rapisarda, A, Kraus, M, Kang, S, Keefe, RSE, and Lee, J. "Establishing the Brief Assessment of Cognition - Short form." Journal of psychiatric research 93 (October 2017): 1-11. Full Text

Keefe, RSE, Davis, VG, Harvey, PD, Atkins, AS, Haig, GM, Hagino, O, Marder, S, Hilt, DC, and Umbricht, D. "Placebo Response and Practice Effects in Schizophrenia Cognition Trials." JAMA psychiatry 74.8 (August 2017): 807-814. Full Text

Xavier, RM, Pan, W, Dungan, JR, Keefe, RSE, and Vorderstrasse, A. "Unraveling interrelationships among psychopathology symptoms, cognitive domains and insight dimensions in chronic schizophrenia." Schizophrenia research (July 7, 2017). Full Text

Mazhari, S, Ghafaree-Nejad, AR, Soleymani-Zade, S, and Keefe, RSE. "Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia." Asian journal of psychiatry 27 (June 2017): 12-15. Full Text

Hochberger, WC, Combs, T, Reilly, JL, Bishop, JR, Keefe, RSE, Clementz, BA, Keshavan, MS, Pearlson, GD, Tamminga, CA, Hill, SK, and Sweeney, JA. "Deviation from expected cognitive ability across psychotic disorders." Schizophrenia research (May 22, 2017). Full Text

Keefe, RSE, and Kahn, RS. "Cognitive Decline and Disrupted Cognitive Trajectory in Schizophrenia." JAMA psychiatry 74.5 (May 2017): 535-536. Full Text

Georgiades, A, Davis, VG, Atkins, AS, Khan, A, Walker, TW, Loebel, A, Haig, G, Hilt, DC, Dunayevich, E, Umbricht, D, Sand, M, and Keefe, RSE. "Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients." Schizophrenia research (April 19, 2017). Full Text

Atkins, AS, Tseng, T, Vaughan, A, Twamley, EW, Harvey, P, Patterson, T, Narasimhan, M, and Keefe, RSE. "Validation of the tablet-administered Brief Assessment of Cognition (BAC App)." Schizophrenia research 181 (March 2017): 100-106. Full Text

Reilly, JL, Hill, SK, Gold, JM, Keefe, RSE, Clementz, BA, Gershon, E, Keshavan, MS, Pearlson, G, Tamminga, CA, and Sweeney, JA. "Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder." Schizophrenia bulletin 43.2 (March 2017): 397-406. Full Text

Pages

Vance, M, Pappadopulos, E, Keefe, R, and Kalali, A. "Conceptual issues in cultural adaptation and the role of culture in assessment of health-related quality of life in schizophrenia." Beyond Assessment of Quality of Life in Schizophrenia. January 1, 2016. 53-62. Full Text

Eum, S, Hill, SK, Rubin, LH, Carnahan, RM, Reilly, JL, Ivleva, EI, Keedy, SK, Tamminga, CA, Pearlson, GD, Clementz, BA, Gershon, ES, Keshavan, MS, Keefe, RSE, Sweeney, JA, and Bishop, JR. "Cognitive burden of anticholinergic medications in psychotic disorders." April 5, 2017. Full Text

Graham, KA, Keefe, RS, Lieberman, JA, Calikoglu, AS, Lansing, KM, and Perkins, DO. "Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia." October 2015. Full Text

Madhoo, M, Roth, RM, Keefe, RSE, Sambunaris, A, Scheckner, B, Nielsen, J, Adeyi, B, Wu, J, and Lasser, R. "Lisdexamfetamine dimesylate augmentation effects on executive function in major depressive disorder based on depressive symptom levels." October 2012.

Madhoo, M, Keefe, RSE, Roth, RM, Sambunaris, A, Wu, J, Trivedi, MH, Anderson, CS, and Lasser, R. "Efficacy and safety of lisdexamfetamine dimesylate in adults with executive dysfunction and partial or full remission of major depressive disorder." June 2012.

Supina, D, Endicott, J, Madhoo, M, Keefe, RSE, Trivedi, M, Wu, J, Scheckner, B, and Lasser, R. "EFFECTS OF LISDEXAMFETAMINE DIMESYLATE AUGMENTATION ON FUNCTIONAL OUTCOMES IN ADULTS WITH PARTIALLY OR FULLY REMITTED MAJOR DEPRESSIVE DISORDER." June 2012.

Uchida, H, Sakurai, H, Bies, RR, Stroup, S, Keefe, RSE, Suzuki, T, Tsuboi, T, Mimura, M, Pollock, BG, and Mamo, DC. "DOPAMINE D2 RECEPTOR OCCUPANCY AND COGNITION IN SCHIZOPHRENIA: ANALYSIS OF THE CATIE DATA." April 2012.

Colijn, MA, Barbato, M, Keefe, RSE, Perkins, DO, Woods, SW, and Addington, J. "AT RISK FOR PSYCHOSIS: THE ROLE OF COGNITION." April 2012.

Keefe, RSE, Buchanan, RW, Marder, SR, Schooler, NR, Dugar, A, Zivkov, M, and Stewart, M. "CLINICAL TRIALS OF POTENTIAL COGNITIVE-ENHANCING DRUGS IN SCHIZOPHRENIA: WHAT HAVE WE LEARNED SO FAR?." April 2012.

Pages

Auditory Perception and Emotion Recognition in Young People at Risk for Psychosis awarded by National Institutes of Health (Principal Investigator). 2016 to 2018

FAST- MAS Phase 2A awarded by National Institutes of Health (Co Investigator). 2013 to 2017

Specific Auditory Perception Impairment and Emotion Recognition in Schizophrenia awarded by National Institutes of Health (Principal Investigator). 2014 to 2017

FAST- MAS Administrative Task Year 3 awarded by National Institutes of Health (Co Investigator). 2014 to 2015

Neural Circuitry And Cognitive Function In Schizophrenia awarded by National Institutes of Health (Principal Investigator). 1995 to 2001

Neural Circuitry & Cognitive Function In Schizophrenia awarded by National Institutes of Health (Principal Investigator). 1995 to 1999

Neural Circuitry & Function In Schizophrenia awarded by National Institutes of Health (Principal Investigator). 1995 to 1999

Neural Corcuitry And Cognitive Function In Schizophrenia awarded by National Institutes of Health (Principal Investigator). 1995 to 1999